Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management under the brand name Zepbound
It can lead to a better functioning metabolism, aids in weight management, and promotes nutrient utilization
The injections I administer are all prescribed in the UK as hydroxocobalamin
A: Coverage varies by insurance plan and medical necessity
US$ 21.82
US$ 26.86
US$ 26.76
US$ 25.12
US$ 28.64
